The technical and techno-legal experts possessing 20 to 30 years of experience in implementing stringent pharmaceutical regulatory norms/requirements shall facilitate and liaise with your organisation for implementing the requirements as per new revised Schedule-M, notified by CDSCO on 28-12-2023, in a time bound manner. The project involves the following elements; 1. Setting up a robust Quality Management System for the organisation. 2. Documentation system based on national and international standards covering entire aspects of revised Schedule-M. 3. Validation of equipment, Machineries and Process. 4. Training of staff/employees on Revised Schedule-M and pathway for implementation. 5. Performing/conducting Audits and monitoring the implementation of Revised Schedule-M.